BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
GATA1
,
T cell differentiation
,
Ischemia
,
Hypothalamus
,
Hematopoietic cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nfkb1 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Cervical cancer wildtype or NFKB1-null HeLa cells treated with various NFKB activators
Embryonic kidney HEK293T wildtype or NFKB1S80A phosphorylated cells treated with TNFa
Effect of TNF treatment in HeLa cells with active or inactive NFkB signalling
U-87 glioma cell line with NFkB subunit p105 shRNA knockdown and temozolomide (TMZ) treatment
HEK293T cells over-expressing RELA and NFKB1 for 48hr
Explore Curated Studies Results
Literature
Most Relevant Literature
A common NFKB1 variant detected through antibody analysis in UK Biobank predicts risk of infection a…
The role of SARS-CoV-2-mediated NF-κB activation in COVID-19 patients.
Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency a…
Long-term environmental metal exposure is associated with hypomethylation of CpG sites in NFKB1 and …
Identification of a Novel Nonsense Mutation in NFKB1 Causing Common Variable Immunodeficiency with D…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatmen…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ